Asia Pacific Transdermal Medical Patch Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Single Layer Drug-in-Adhesive, Multi-layer Drug-in-Adhesive, Reservoir, Vapor Patch, and Matrix), Application (Neurologic Conditions, Pain Ma

Asia Pacific Transdermal Medical Patch Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Single Layer Drug-in-Adhesive, Multi-layer Drug-in-Adhesive, Reservoir, Vapor Patch, and Matrix), Application (Neurologic Conditions, Pain Management, Nicotine Cessation, Cardiovascular Disorders, Hormonal Therapy, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)

The Asia Pacific transdermal medical patch market is expected to grow from US$ 2,126.31 million in 2023 to US$ 2,744.32 million by 2028. It is estimated to register a CAGR of 5.2% from 2023 to 2028.

Advancements in Smart Patches and Three-Dimensional (3D)-Printed Patches Fuel Asia Pacific Transdermal Medical Patch Market

The transdermal drug administration route is novel and one of the reliable means of sustained drug delivery. With significant research being carried out in this field and increasing interest of researchers in this form of drug delivery, the number of transdermal patches reaching the marketplace is expected to rise sharply. Transdermal patches have attracted attention for decades and were used to deliver drugs such as nicotine, fentanyl, nitroglycerin, and clonidine to treat various diseases or conditions.

According to a study titled A smart hydrogel patch with high transparency, adhesiveness, and hemostasis for all-round treatment and glucose monitoring of diabetic foot ulcers, published in 2022, scientists have developed an intelligent patch to monitor and treat diabetic foot ulcers. This system is fabricated from conductive hydrogel patches with an ultra-high transparency polymer network.

Researchers are using 3D printing technology to create customized transdermal patches (e.g., a 3D-printed patch for wound healing) tailored as per patient's needs. In a study by Jang et al. titled Gelatin Methacrylate Hydrogel for Tissue Engineering Applications—A Review on Material Modifications, published in 2022, gelatin methacrylate (GelMA) was tested as a viable option with tunable physical properties. GelMA hydrogel incorporating a vascular endothelial growth factor (VEGF)-mimicking peptide was successfully printed using a 3D bio-printer due to the hydrogel inks' shear-thinning properties. The 3D structure of the hydrogel patch had high porosity and water absorption properties. Slowly released from hydrogel patches, VEGF peptide can promote cell viability, proliferation, and tubular structure formation, indicating that the 3D Gel-MA-VEGF hydrogel patch can be used for wound dressing.

In this study, two liquid monomers—polyethylene glycol diacrylate (PEGDA) and vinylpyrrolidone (VP)—in different proportions were used to improve the mechanical strength, polymerization rate, and swelling rate of the final polymer. Optimal drug loading on the resin indicated that AHP-3 remained stable throughout the manufacturing process and had no effect on the physical properties of the final polymer. Using a 3D scanned facial model, a personalized patch was designed in computer-aided design software and fabricated in optimized resin using a digital light processing 3D printer. In vitro characterization of the prepared transdermal patches showed their ability to penetrate human cadaver skin, and they remained intact after compression.

Asia Pacific Transdermal Medical Patch Market Overview

The transdermal medical patch market in Asia Pacific is segmented into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. The regional growth is attributed to growing research on cancer and gene mutations, increasing disease modeling, and developments by market players offering transdermal medical patch. Factors such as developing healthcare facilities, growing aging population to share key facts associated with stem cell technologies, and increasing partnerships with foreign entities are likely to further propel the market growth during the forecast period.

Asia Pacific Transdermal Medical Patch Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Transdermal Medical Patch Market Segmentation

The Asia Pacific transdermal medical patch market is segmented into type, application, distribution channel, and country.

Based on type, the Asia Pacific transdermal medical patch market is segmented into single-layer drug in-adhesive, multi-layer drug in-adhesive, reservoir, vapor patch, and matrix. The matrix segment registered the largest market share in Asia Pacific transdermal medical patch market in 2023.

Based on application, the Asia Pacific transdermal medical patch market is segmented into neurologic conditions, pain management, nicotine cessation, cardiovascular disorders, hormonal therapy, and others. The pain management segment held the largest market share in 2023.

Based on distribution channel, the Asia Pacific transdermal medical patch market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment held the largest market share in 2023.

Based on country, the Asia Pacific transdermal medical patch market is segmented into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. Japan dominated the market share in 2022.

Boehringer Ingelheim International GmbH, Endo International Inc, Hisamitsu Pharmaceutical Co Inc, Johnsons and Johnsons, Medline Industries LP, Novartis AG, Teva Pharmaceutical Industries Ltd., and Viatris Inc are the leading companies operating in the transdermal medical patch market in the region.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific transdermal medical patch market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific transdermal medical patch market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving transdermal medical patch market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution